Stocks and Investing
Stocks and Investing
Wed, May 19, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Kristen Kluska Initiated (TSHA) at Buy and Held Target at $44 on, May 19th, 2021
Kristen Kluska of Cantor Fitzgerald, Initiated "Taysha Gene Therapies, Inc." (TSHA) at Buy and Held Target at $44 on, May 19th, 2021.
Kristen has made no other calls on TSHA in the last 4 months.
There are 3 other peers that have a rating on TSHA. Out of the 3 peers that are also analyzing TSHA, 0 agree with Kristen's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Kristen
- Gbola Amusa of "Chardan Capital" Maintained at Strong Buy with Increased Target to $68 on, Tuesday, April 13th, 2021
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $43 on, Tuesday, April 13th, 2021
- Raju Prasad of "William Blair" Initiated at Buy and Held Target at $46 on, Wednesday, February 24th, 2021
Contributing Sources